[Federal Register Volume 60, Number 191 (Tuesday, October 3, 1995)]
[Notices]
[Pages 51803-51804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-24561]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart, Lung, and Blood Special Emphasis Panel (SEP) meetings:

[[Page 51804]]

    Name of SEP: Review on Infant Heart Surgery: CNS Sequelae of 
Circulatory Arrest.
    Date: October 29, 1995.
    Time: 8:10 p.m.
    Place: Hyatt Regency Bethesda.
    Contact Person: David M. Monsees, Rockledge II, Room 7178, 
Bethesda, Maryland 20892-7924, (301) 435-0270.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Review on Risk Factors in Early Human 
Atherogenesis.
    Date: October 30, 1995.
    Time: 8:30 a.m.
    Place: Hyatt Regency Bethesda.
    Contact Person: David M. Monsees, Rockledge II, Room 7178, 
Bethesda, Maryland 20892-7924, (301) 435-0270.
    Purpose/Agenda: To review and evaluate grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: September 27, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-24561 Filed 10-2-95; 8:45 am]
BILLING CODE 4140-01-M